With our unique and established capabilities and strategy for growth, we offer a clear proposition to investors.
Find out how our business model, strategy and established capabilities support our clear investment proposition.
Find out how we are performing in our Annual Report.
18 May 2018
Interim Management Statement (May)
15 August 2018
Interim Results Announcement
8 November 2018
Interim Management Statement
News feed from the London Stock Exchange's Regulatory News Service.
25 April 2018
Block listing Interim Review
24 April 2018
Hikma expands licensing agreement with Rovi
20 April 2018
Hikma launches Dexrazoxane for Injection
Up-to-date information including full share price details plus investor tools.
at 11:07 on 25 Apr 2018
Price can be delayed by 15 minutes
Information on the high standards of governance we’re committed to, our governance structure, Board, key committees, and remuneration policy.
Historical summary of our financial results and key performance indicators.